Investigating the Relationship between Pharmacokinetics/pharmacodynamics of Vancomycin and Clinical Outcome for <i>Enterococcus faecium</i> Bloodstream Infection: a Single-center Retrospective Study-Reference-Cited by-同舟云学术

Investigating the Relationship between Pharmacokinetics/pharmacodynamics of Vancomycin and Clinical Outcome for <i>Enterococcus faecium</i> Bloodstream Infection: a Single-center Retrospective Study

Published:2023-04-10 Issue:4 Volume:49 Page:143-152
ISSN:1346-342X
Container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
language:en
Short-container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)

Author:

Shimizu Seika¹,Nakano Takafumi¹²,Eguchi Yukiomi¹,Moriwaki Norihiro¹²,Ikeuchi Tadahiro¹,Togawa Atsushi²³,Kaneshige Susumu¹,Kamimura Hidetoshi¹

Affiliation:

1. Department of Pharmacy, Fukuoka University Hospital

2. Department of Infection Control, Fukuoka University Hospital

3. Department of Medical Oncology, Hematology, and Infectious Diseases, Faculty of Medicine, Fukuoka University

Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Link

https://www.jstage.jst.go.jp/article/jjphcs/49/4/49_143/_pdf

Reference29 articles.

1. 1）Low DE, Keller N, Barth A, Jones RN, Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999, Clin Infect Dis, 2001, 32, S133-S145.

2. 2）Cattoir V, Giard JC, Antibiotic resistance in Enterococcus faecium clinical isolates, Expert Rev Anti Infect Ther, 2014, 12, 239-248.

3. 3）Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A, Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review, Eur J Clin Pharmacol, 2012, 68, 1243-1255.

4. 4）van Hal SJ, Paterson DL, Lodise TP, Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter, Antimicrob Agents Chemother, 2013, 57, 734-744.

5. 5）Covert KL, Knoetze D, Cole M, Lewis P, Vancomycin plus piperacillin/tazobactam and acute kidney injury risk: A review of the literature, J Clin Pharm Ther, 2020, 45, 1253-1263.